$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
阿来替尼漏服了要怎么办?
2025-10-19 11:44:20
Check Details
阿来替尼在医保范围内吗?
2025-10-19 11:44:20
Check Details
克唑替尼治疗肺癌服用量多少?
2025-10-19 11:44:20
Check Details
肺腺癌可以服用克唑替尼吗?
2025-10-19 11:44:20
Check Details
晚期非小细胞肺癌用克唑替尼可延长生存期多久?
2025-10-19 11:44:20
Check Details
肺癌治疗药物阿来替尼去哪买?
2025-10-19 11:44:20
Check Details
克唑替尼国内医保报销后实付多少?
2025-10-19 11:44:20
Check Details
肺癌患者吃克唑替尼多久会耐药?
2025-10-19 11:44:20
Check Details
服用克唑替尼注意事项
2025-10-19 11:44:20
Check Details
克唑替尼服用多长时间会耐药?
2025-10-19 11:44:20
Check Details
肺癌ALK突变靶向药克唑替尼(赛可瑞)说明书
2025-10-19 11:44:20
Check Details
非小细胞肺癌靶向治疗药物-色瑞替尼
2025-10-19 11:44:20
Check Details
1
2
...
3665
3666
3667
3668
3669
3670
3671
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
2
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
3
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
4
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
5
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
6
Cemiplimab (Libtayo) Drug Information
7
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
8
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
9
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
10
A Revolutionary Targeted Therapy for Hematological Malignancies
11
A New Option for Advanced Renal Cell Carcinoma Treatment
12
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description: